The benefits of transitioning from paper-based to paperless batch record management

29 Oct 2019

Free webinar to discuss the benefits of a collaborative approach to implementing an electronic batch record platform.

Lonza will host a free 60-minute webinar (on 12 November) during which Nephron Pharmaceuticals will explain its decision to take a paperless approach to batch record management.

The benefits of transitioning from paper-based to paperless batch record management

Nephron will also discuss how its close relationship with Lonza allowed for a rapid implementation of Lonza’s MODA-ES electronic batch record (EBR) Platform in just 9 months, leading to increased operational efficiency and expanded product lines.

Recording batch data is an essential part of the pharmaceutical manufacturing process. However, the wealth of information generated by each batch is traditionally collected using paper-based workflows, which are inherently resource intensive, time consuming and can negatively impact the time-to-market for new therapeutics. As such, pharmaceutical manufacturers are increasingly turning to paperless EBR solutions to eliminate these challenges.

In the webinar titled “Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success,” Bryan Beck, Vice President for Automation and Information Technology at Nephron Pharmaceuticals, will discuss the following topics:

  • Why Nephron implemented an EBR Platform.
  • How the collaborative approach to expedited implementation resulted in an EBR platform with a user-friendly and configurable design.
  • How the implementation of Lonza’s MODA-ES EBR Platform at Nephron has enabled compliance with regulatory requirements while driving growth and operational efficiency.
  • Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success

    Speaker: Bryan Beck; Moderator: Geoffrey Swafford, Senior Manager for MODA Implementation at Lonza Bioscience Solutions

  • Tuesday, 12 November 2019
  • 8 AM PST (Los Angeles)
  • 11 AM EST (New York)
  • 4 PM GMT (London)
  • 5 PM CET (Berlin)
  • Read More

    Related news

    New microbial air sampler addresses continuous monitoring

    New microbial air sampler addresses continuous monitoring

    14 Nov 2019

    The device supports the new EU GMP Annex 1 requirements.

    Read more 
    GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’

    GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’

    13 Nov 2019

    China-US trade challenges has led to de-risking by pharma companies.

    Read more 
    Winners of the 16th Pharma Awards

    Winners of the 16th Pharma Awards

    11 Nov 2019

    Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment.

    Read more 
    CDMOs to benefit from rising BTDs, orphan drugs and fast track status therapies

    CDMOs to benefit from rising BTDs, orphan drugs and fast track status therapies

    8 Nov 2019

    But personalized medicines will require new logistics and manufacturing systems.

    Read more 
    SGH Healthcaring unveils its new asthma spacer device

    SGH Healthcaring unveils its new asthma spacer device

    8 Nov 2019

    Zephyr's revolutionary new design improves drug administration and simplifies treatment delivery for better observance.

    Read more 
    Recipharm expands Indian injectable dosage form capabilities

    Recipharm expands Indian injectable dosage form capabilities

    7 Nov 2019

    Partnership will combine capabilities and expertise in Europe and India to build a new facility dedicated to injectable formulations to supply demand from Europe and overseas territories.

    Read more 
    Aptar acquires a leader in drug delivery training devices and patient onboarding

    Aptar acquires a leader in drug delivery training devices and patient onboarding

    6 Nov 2019

    Acquisition reflects movement of treatments being administered by patients at home rather than by healthcare providers.

    Read more 
    Europe predicted to surpass the US in biologic manufacturing capacity by 2023

    Europe predicted to surpass the US in biologic manufacturing capacity by 2023

    6 Nov 2019

    Demand for biological manufacturing is growing faster than capacity growth.

    Read more 
    SP acquires Spain based global provider of complete sterile filling lines

    SP acquires Spain based global provider of complete sterile filling lines

    5 Nov 2019

    Company's strategic move reflects its expectation of short-run aseptic liquid filling to continue to drive pharmaceutical growth.

    Read more 
    Legacy recruits heavily to meet growing steriles demand

    Legacy recruits heavily to meet growing steriles demand

    5 Nov 2019

    Company to reach 250 employees by year end to meet growing drug product manufacturing demand.

    Read more